![]() BioArctic BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases. | ![]() Appello Pharmaceuticals Appello Pharmaceuticals is a preclinical-stage company that discovers and develops novel positive allosteric modulators for the treatment of Parkinson's disease. | ![]() 3B Pharmaceuticals 3B Pharmaceuticals (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications. | |||
Founding Date | Founding Date 2000 | Founding Date 2002 | Founding Date 2003 | Founding Date N/A | Founding Date 2008 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Amsterdam, NL HQ Villeurbanne, FR | Locations TW HQ Walnut, US | Locations Stockholm , SE HQ | Locations Nashville, US HQ | Locations Berlin, DE HQ |
Employees | Employees 133 | Employees 522% decrease | Employees 107 | Employees N/A | Employees 5510% increase |
Valuation ($) | Valuation ($) 38.3 m | Valuation ($) N/A | Valuation ($) 1.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €11.8m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) kr2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods €4.3m (FY, 2018) | Cost of goods N/A | Cost of goods kr59.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €7.5m (FY, 2018) | Gross profit N/A | Gross profit kr1.9b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (€18.5m) (FY, 2018) | Net income N/A | Net income kr1b (FY, 2025) | Net income N/A | Net income N/A |
Abnova is a biotech company specializing in antibody and protein production.
View company
BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.
View company
Appello Pharmaceuticals is a preclinical-stage company that discovers and develops novel positive allosteric modulators for the treatment of Parkinson's disease.
View company
3B Pharmaceuticals (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications.
View company